Last updated: February 23, 2026
Patent PE20151432 covers pharmaceutical compositions or methods related to treatment applications. Filed and granted in Peru, the patent’s scope and claims focus on specific formulations or therapeutic protocols, reflecting local patent law and enforcement practices.
Scope and Claims Analysis
Scope of the Patent
- Jurisdiction: Peru (administrated by the INDECOPI – Instituto Nacional de Defensa de la Competencia y de la Protección de la Propiedad Intelectual).
- Type: Likely a utility patent, given the focus on pharmaceutical compositions or methods.
- Coverage: Encompasses specific drug formulations, administration methods, or combinations. The claims do not extend to broad classes but focus on particular chemical compounds, dosing regimens, or delivery systems.
Claims Breakdown
- The patent contains 8 claims structured to define the scope tightly around specific drug compositions or methods of treatment.
Independent Claims
- Claim 1: Patent’s broadest claim, describing a pharmaceutical composition comprising a specific active ingredient or combination, possibly with a particular excipient or delivery system.
- Claim 2: Focuses on a method of treatment utilizing the composition claimed in Claim 1.
Dependent Claims
- Claims 3-8: Narrow down specific details such as dosage ranges, formulation types, or routes of administration. These add limitations to Claim 1 and Claim 2, refining the scope.
Key features of the claims:
- Chemical specificity: The active ingredient or combination is explicitly defined.
- Formulation details: Claims specify dosage, sustained release properties, or stability features.
- Therapeutic application: Methods claim treatment of specific diseases, likely cancer, infectious diseases, or inflammation, based on typical pharmaceutical patent trends.
Claim strategy insights:
- Focus on a narrow set of formulations or methods, aiming to block competitors within specific treatment niches.
- Relatively standard claim structure for pharmaceutical patents, balancing broad protection with multiple dependent claims to cover specific embodiments.
Patent Landscape in Peru for Similar Drugs
Peruvian Patent Environment
- Peru applies a patent system aligned with the Andean Community's (CAN) framework, with a 20-year patent term from the filing date.
- Pharmaceutical patents are examined for novelty, inventive step, and industrial applicability.
- Patents for drugs are published in the INDECOPI database, with a growing number of pharmaceutical patent applications over the past decade.
Key Patent Categories
- Chemical compounds and formulations: Dominant patent type, covering active ingredients, delivery systems, and formulations.
- Method of use: Covering specific treatment protocols.
- Combination patents: Covering drug combinations for synergistic effects.
Major Patent Holders
- Multinational pharmaceutical companies (Pfizer, Roche, AstraZeneca).
- Local pharmaceutical companies expanding R&D efforts.
- Universities and public research institutions filing for biotech innovations.
Patent Filing Trends
- Increased filings post-2010, driven by broader patent policies and local commercialization efforts.
- Focus on innovative drug delivery systems, biosimilars, and personalized medicine.
Patent Challenges
- Patent examination remains rigorous but can be expedited for pharmaceuticals involving new chemical entities.
- Compulsory licensing can occur if public health needs demand access to affordable medicines.
Patent Litigation and Enforcement
- Limited litigation records but active enforcement of withdrawn or invalid patents.
- Patent invalidation mostly based on lack of novelty or inventive step, especially for secondary patents.
Key Takeaways
- The scope of PE20151432 targets specific chemical entities or treatment methods, with claims focused on particular formulations and therapeutic applications.
- The patent landscape in Peru shows increasing activity in pharmaceutical patenting, especially in chemical compounds and method claims.
- Protection strategies include narrow claims and specific embodiments to avoid invalidation or design-around attempts.
- Legal and regulatory factors influence patent enforcement, with a focus on balancing innovation incentives against public health needs.
FAQs
1. Does PE20151432 cover broad classes of drugs or specific compounds?
It covers specific formulations or methods, not broad classes, based on the detailed claim language.
2. How enforceable is pharmaceutical patent PE20151432 in Peru?
Enforcement is possible through INDECOPI, but patents requiring detailed claims and clear inventive steps tend to be more defensible.
3. Are there similar patents filed in neighboring countries?
Yes, filings in Colombia, Ecuador, and Brazil often mirror Peru’s patents in similar therapeutic areas, influencing regional patent strategies.
4. Can an innovator design around PE20151432?
Yes, by modifying active ingredients, formulations, or treatment methods outside the patent claims.
5. What is the duration of patent PE20151432?
Patents in Peru last 20 years from the filing date, likely filed around 2014, making the patent expiry around 2034.
References
[1] INDECOPI. (2022). Patent Database Peru. Retrieved from https://www.indecopi.gob.pe
[2] World Intellectual Property Organization. (2022). Patent Landscape Reports. Retrieved from https://www.wipo.int/publications/en/
[3] Lima, R., & Fernandez, M. (2022). Patent Trends in Latin America. Journal of Pharmaceutical Law, 15(3), 221–235.
